Brick & Kyle Associates’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Brick & Kyle Associates’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-275	Closed	-$33K	–	386
2017 Q1	$33K	Buy	275 +75	+38%	+$9.2K	0.03%	217
2016 Q4	$22K	Hold	200	–	–	0.02%	272
2016 Q3	$27K	Hold	200	–	–	0.02%	236
2016 Q2	$18K	Hold	200	–	–	0.01%	291
2016 Q1	$14K	Hold	200	–	–	0.01%	312
2015 Q4	$14K	Hold	200	–	–	0.01%	305
2015 Q3	$18K	Hold	200	–	–	0.02%	278
2015 Q2	$25K	Hold	200	–	–	0.02%	248
2015 Q1	$18K	Sell	200 -100	-33%	-$8.12K	0.02%	296
2014 Q4	$20K	Buy	+300	New	+$21.9K	0.02%	274

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Brick & Kyle Associates's GWPH Position: Q2 2017 in Review

Brick & Kyle Associates sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2017, closing a stake of 275 shares — an estimated $33K sold.

Brick & Kyle Associates first reported a position in GWPH in Q4 2014 and held it in 10 quarters. The position peaked at $33K in Q1 2017. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

Brick & Kyle Associates reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2017 after selling out during the quarter.
Brick & Kyle Associates sold 275 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $33K.
Brick & Kyle Associates first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2014 and held it in 10 quarters.
Brick & Kyle Associates's GW Pharmaceuticals Plc American Depositary Shares position peaked at $33K in Q1 2017.
170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on Brick & Kyle Associates's 13F filing for Q2 2017, filed 14 Aug 2017.